Endo Slams DQ Bid For BakerHostetler Atty In Opioid MDL
Endo Pharmaceuticals Inc. on Wednesday hit back at a motion to disqualify a BakerHostetler partner— and former U.S. attorney who worked on the opioid crisis— from bellwether cases in the opioid...To view the full article, register now.
Already a subscriber? Click here to view full article